Úsek pro vědu a výzkum

Professional Publications

Author
Title
Year of publication

Publications (3663)

[821]

Lopotová, T.; Polák, J.; Schwarz, J.; Klamová, H.; Moravcová, J.

Expression of four major WT1 splicing variants in acute and chronic myeloid leukemia patients analyzed by newly developed four real-time RT PCRs

[year of publication 2012, impact factor 2.259 ]

[822]

Kideryová, L.; Pytlík, R.; Benešová, K.; Veselá, R.; Karban, J.; Rychtrmocová, H.; Goettsch, W.; Morawietz, H.; Trněný, M.

Endothelial cells (EC) and endothelial precursor cells (EPC) kinetics in hematological patients undergoing chemotherapy or autologous stem cell transplantation (ASCT)

[year of publication 2010, impact factor 2.258]

[823]

Tachezy, R.; Hamsikova, E.; Valvoda, J.; Van Ranst, M.; Betka, J.; Burk, R.D.; Vonka, V.

Antibody response to a synthetic peptide derived from the human papillomavirus type 6/11 L2 protein in recurrent respiratory papillomatosis : correlation between Southern blot hybridization, polymerase chain reaction, and serology

[year of publication 2006, impact factor 2.246]

[824]

Škvor, J.; Lipovová, P.; Poučková, P.; Souček, J.; Slavík, T.; Matoušek, J.

Effect of wheat leaf ribonuclease on tumor cells and tissues

[year of publication 2006, impact factor 2.245]

[825]

Čermák, J.; Vítek, A.; Michalová, K.

Combined stratification of refractory anemia according to both WHO and IPSS criteria has a prognostic impact and improves identification of patients who may benefit from stem cell transplantation

[year of publication 2006, impact factor 2.244]

[826]

Moravcová, J.; Zmeková, V.; Klamová, H.; Voglová, J.; Faber, E.; Michalová, K.; Rabasová, J.; Jarošová, M.

Differences and similarities in kinetics of BCR-ABL transcript levels in CML patients treated with imatinib mesylate for chronic or accelerated disease phase

[year of publication 2006, impact factor 2.244]

[827]

Bruchova, H.; Kalinova, M.; Brdicka, R.

Array-based analysis of gene expression in childhood lymphoblastic leukemia

[year of publication 2006, impact factor 2.244]

[828]

Sieglová, Z.; Žilovcová, S.; Čermák, J.; Říhová, H.; Březinová, D.; Dvořáková, R.; Marková, M.; Maaloufová, J.; Sajdová, J.; Březinová, J.; Zemanová, Z.; Michalová, K.

Dynamics of telomere erosion and its association with genome instability in myelodysplastic syndromes (MSD) and acute myelogenous leukemia arising from MDS : a marker of disease prognosis?

[year of publication 2006, impact factor 2.244]

[829]

Tachezy, R.; Saláková, M.; Hamšíková, E.; Kaňka, J.; Havránková, A.; Vonka, V.

Prospective study on cervical neoplasia : presence of HPV DNA in cytological smears precedes the development of cervical neoplasia lesions

[year of publication 2006, impact factor 2.243]

[830]

Merkerova, M.; Belickova, M.; Bruchova, H.

Differential expression of microRNAs in hematopoietic cell lineages

[year of publication 2008, impact factor 2.237]

[831]

Kotlín, R.; Sobotková, A.; Suttnar, J.; Salaj, P.; Walterová, L.; Riedel, T.; Reicheltová, Z.; Dyr, J.E.

A novel fibrinogen variant - Liberec : dysfibrinogenaemia associated with gamma Tyr262Cys substitution

[year of publication 2008, impact factor 2.237]

[832]

Smahel, M.; Polakova, I.; Pokorna, D.; Ludvikova, V.; Duskova, M.; Vlasak, J.

Enhancement of T cell-mediated and humoral immunity of beta-glucuronidase-based DNA vaccines against HPV16 E7 oncoprotein

[year of publication 2008, impact factor 2.234]

[833]

Sobotkova, E.; Duskova, M.; Eckschlager, T.; Vonka, V.

Efficacy of reovirus therapy combined with cyclophosphamide and gene-modified cell vaccines on tumors induced in mice by HPV16-transformed cells

[year of publication 2008, impact factor 2.234]

[834]

Lakatosova-Andelova, M.; Jinoch, P.; Duskova, M.; Marinov, I.; Vonka, V.

Live cell vaccines expressing B7.1, monocyte chemoattractant protein 1 and granulocyte-macropage colony stimulation factor derived from mouse HPV-16-transformed cells

[year of publication 2008, impact factor 2.234]

[835]

Hůlková, H.; Ledvinová, J.; Asfaw, B.; Koubek, K.; Kopřiva, K.; Elleder, M.

Lactosylceramide in lysosomal storage disorders : a comparative immunohistochemical and biochemical study.

[year of publication 2006, impact factor 2.224]

[836]

Šroller, V.; Hamšíková, E.; Ludvíková, V.; Vochozková, P.; Kojzarová, M.; Fraiberk, M.; Saláková, M.; Morávková, A.; Forstová, J.; Němečková, Š.

Seroprevalence rates of BKV, JCV, and MCPyV polyomaviruses in the general Czech Republic population

[year of publication 2013, impact factor 2.217 ]

[837]

Sutherland, D.R.; Illingworth, A.J.; Whitby, L.; Marinov, I.

Re Gatti et al (Eur J Haematol 2017 Mar 23. doi: 10.1111/ejh.12885)

[year of publication 2018, impact factor 2.217 ]

[838]

Hatalova, A.; Schwarz, J.; Gotic, M.; et al.

Recommendations for the diagnosis and treatment of patients with polycythaemia vera

[year of publication 2018, impact factor 2.217 ]

[839]

Roubalova, K.; Strunecky, O.; Vitek, A.; Zufanova, S.; Prochazka, B.

Genetic variability of cytomegalovirus glycoprotein O in hematopoietic stem cell transplant recipients

[year of publication 2011, impact factor 2.216 ]

[840]

Barnes, D.M.; Bartkova, J.; Camplejohn, R.S.; Gullick, W.J.; Smith, P.J.; Millis, R.R.

Overexpression of the c-erbB-2 oncoprotein : why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance?

[year of publication 2006, impact factor 2.191]